Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    May 2018
  1. RATNER L, Waldmann TA, Janakiram M, Brammer JE, et al
    Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy.
    N Engl J Med. 2018;378:1947-1948.
    PubMed     Text format    


    April 2018
  2. BORCHARD NA, Nayak JV
    Orbital Apex Syndrome.
    N Engl J Med. 2018;378:e23.
    PubMed     Text format    


  3. CANELLOS GP, LaCasce AS
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1560.
    PubMed     Text format    


  4. CRUMP M
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559-60.
    PubMed     Text format    


  5. GREER JP
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559.
    PubMed     Text format    


  6. HILAL T
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-9.
    PubMed     Text format    



  7. Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-1561.
    PubMed     Text format    


  8. SCHMITZ R, Wright GW, Huang DW, Johnson CA, et al
    Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1396-1407.
    PubMed     Text format     Abstract available


    March 2018
  9. TAM CS, Anderson MA, Pott C, Agarwal R, et al
    Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
    N Engl J Med. 2018;378:1211-1223.
    PubMed     Text format     Abstract available


  10. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    PubMed     Text format    


  11. QUINTAS-CARDAMA A
    CAR T-Cell Therapy in Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1065.
    PubMed     Text format    



  12. CAR T-Cell Therapy in Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1065.
    PubMed     Text format    


  13. YARCHOAN R, Uldrick TS
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:1029-1041.
    PubMed     Text format    



  14. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:878.
    PubMed     Text format    


    December 2017
  15. NAIR R, Tabchi S, Hagemeister F
    Obinutuzumab Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:2605.
    PubMed     Text format    



  16. Obinutuzumab Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:2605-2606.
    PubMed     Text format    


  17. SCHUSTER SJ, Svoboda J, Chong EA, Nasta SD, et al
    Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
    N Engl J Med. 2017;377:2545-2554.
    PubMed     Text format     Abstract available


  18. NEELAPU SS, Locke FL, Bartlett NL, Lekakis LJ, et al
    Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMoa1707447.
    PubMed     Text format     Abstract available


  19. LONGO DL, DeVita VT Jr
    Progress in the Treatment of Hodgkin's Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMe1715141.
    PubMed     Text format    


  20. CONNORS JM, Jurczak W, Straus DJ, Ansell SM, et al
    Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMoa1708984.
    PubMed     Text format     Abstract available


    November 2017

  21. More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:2101-2102.
    PubMed     Text format    


  22. TIBERGHIEN P, Deconinck E, Adotevi O
    More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:2101-2.
    PubMed     Text format    


    October 2017
  23. MARCUS R, Davies A, Ando K, Klapper W, et al
    Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:1331-1344.
    PubMed     Text format     Abstract available


  24. ARMITAGE JO, Longo DL
    Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    N Engl J Med. 2017;377:1389-1390.
    PubMed     Text format    


    September 2017
  25. LE GOUILL S, Thieblemont C, Oberic L, Moreau A, et al
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    N Engl J Med. 2017;377:1250-1260.
    PubMed     Text format     Abstract available


  26. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
    Connecting the Dots.
    N Engl J Med. 2017;377:978-984.
    PubMed     Text format    


    August 2017
  27. ABRAMSON JS, McGree B, Noyes S, Plummer S, et al
    Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:783-784.
    PubMed     Text format    


  28. LACASCE AS, Flores EJ, Goldstein RH, Sohani AR, et al
    Case 25-2017.
    N Engl J Med. 2017;377:677-688.
    PubMed     Text format    


    July 2017
  29. MELANI C, Major A, Schowinsky J, Roschewski M, et al
    PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.
    N Engl J Med. 2017;377:89-91.
    PubMed     Text format    


    June 2017
  30. DAVID WS, Bowley MP, Mehan WA Jr, Shin JH, et al
    Case 19-2017 - A 53-Year-Old Woman with Leg Numbness and Weakness.
    N Engl J Med. 2017;376:2471-2481.
    PubMed     Text format    


    April 2017
  31. HOCHBERG EP, Bierer MF, Winkfield KM, Chen YB, et al
    Case 11-2017 - A 61-Year-Old Woman with Leg Swelling, Back Pain, and Hydronephrosis.
    N Engl J Med. 2017;376:1461-1471.
    PubMed     Text format    


    October 2016
  32. MACIOCIA N, O'Brien A, Ardeshna K
    Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    N Engl J Med. 2016;375:1699-1701.
    PubMed     Text format    


  33. HARI P, Raj RV, Olteanu H
    Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.
    N Engl J Med. 2016;375:1501-1502.
    PubMed     Text format    


    September 2016
  34. ADAMS HJ, Kwee TC
    Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
    N Engl J Med. 2016;375:999-1000.
    PubMed     Text format    



  35. Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
    N Engl J Med. 2016;375:999-1000.
    PubMed     Text format    


    July 2016
  36. DAVIDS MS, Kim HT, Bachireddy P, Costello C, et al
    Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
    N Engl J Med. 2016;375:143-53.
    PubMed     Text format     Abstract available


    June 2016
  37. BARTLETT NL
    Fine-Tuning the Treatment of Hodgkin's Lymphoma.
    N Engl J Med. 2016;374:2490-2.
    PubMed     Text format    


  38. JOHNSON P, Federico M, Kirkwood A, Fossa A, et al
    Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
    N Engl J Med. 2016;374:2419-29.
    PubMed     Text format     Abstract available


    April 2016
  39. SCHWARTZ KR, El Saleeby CM, Nimkin K, Friedmann AM, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 11-2016. A 12-Year-Old Boy with Malaise, Fevers, Abdominal Pain, and Pallor.
    N Engl J Med. 2016;374:1466-76.
    PubMed     Text format    


    March 2016
  40. ARMSTRONG GT, Chen Y, Yasui Y, Leisenring W, et al
    Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.
    N Engl J Med. 2016;374:833-42.
    PubMed     Text format     Abstract available


    February 2016
  41. TSUDA K, Tanimoto T, Komatsu T
    Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
    N Engl J Med. 2016;374:792-3.
    PubMed     Text format    


  42. RUAN J, Leonard JP
    Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
    N Engl J Med. 2016;374:793.
    PubMed     Text format    


    January 2016
  43. GAMBACORTI-PASSERINI C, Mussolin L, Brugieres L
    Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib.
    N Engl J Med. 2016;374:95-6.
    PubMed     Text format    


    December 2015
  44. GARNEAU AP, Riopel J, Isenring P
    Acute Methotrexate-Induced Crystal Nephropathy.
    N Engl J Med. 2015;373:2691-3.
    PubMed     Text format    


  45. RADFORD J, Longo DL
    Second Cancers after Treatment for Hodgkin's Lymphoma--Continuing Cause for Concern.
    N Engl J Med. 2015;373:2572-3.
    PubMed     Text format    


  46. SCHAAPVELD M, Aleman BM, van Eggermond AM, Janus CP, et al
    Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    N Engl J Med. 2015;373:2499-511.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: